ITALIAN JOURNAL OF PUBLIC HEALTH Epidemiologia e ... - Ijph.it

IJPH - Year 8, Volume 7, Number 2, Suppl. 2, 2010
I T A L I A N J O U R N A L O F P U B L I C H E A L T H
6) MacGregor AJ, Silman AJ. Rheumatoid arthritis and other
synovial disorders: classification and epidemiology. In:
Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman
MH, editors. Rheumatology, 3rd ed. Mosby: 757-63.
7) Silman AJ, Hochberg MC. Epidemiology of the rheumatic
diseases. 2nd edition. Oxford: Oxford University Press, 2001.
8) Silman A, Bankhead C, Rowlingson B, Brennan P, Symmons
D, Gatrell A. Do new cases of rheumatoid arthritis cluster in
time or in space? Int J Epidemiol 1997;26:628-34.
9) ANMAR. Associazione Nazionale Malati di Artrite
Reumatoide. Disponibile online da http://www.anmar-italia.
it/. [Ultimo accesso maggio 2010].
10) Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical
features of rheumatoid arthritis. Eur J Radiol 1998;27(Suppl
1):S18-24.
11) Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet
2001;358:903–11.
12) Cervini C. L’artrite reumatoide. In: Cervini C, editor.
Manuale di Reumatologia. Torino: UTET, 1996:53–89.
13) Wollheim FA. Rheumatoid arthritis—the clinical pictures.
In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors.
Oxford Textbook of Rheumatology, 30th ed. New York:
Oxford University Press, 1993.
14) Spector TD. Rheumatoid arthritis. Rheum Dis Clin North
Am 1990;16:513–27.
15) Skoldstam L, Hagfors L, Johansson G. An experimental
study of a Mediterranean diet intervention for patients with
rheumatoid arthritis. Ann Rheum Dis 2003;62:208-14.
16) Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil
and olive oil supplementation in patients with rheumatoid
arthritis. Clinical and immunologic effects. Arthritis Rheum
1990;33:810-20.
17) Alamanos Y, Voulgari PV, Drosos AA. Rheumatoid arthritis
in southern Europe: epidemiological, clinical, radiological, and
genetic considerations. Curr Rheum Rev 2005;1:33-6.
18) Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term
outcome of treating rheumatoid arthritis: results after 20 years.
Lancet 1987;1:1108-11.
19) Pincus T, Callahan LF. Taking mortality in rheumatoid
arthritis seriously- predictive markers, socioeconomic status
and comorbidity. J Rheumatol 1986;13:841-5.
20) Van Doornum S, McColl G, Wicks IP. Accelerated
Atherosclerosis An Extra-articular Feature of Rheumatoid
Arthritis? Arthritis Rheum 2002;46(4):862–73.
21) Gonzalez A, Maradit Kremers H, Crowson CS, et al. The
widening mortality gap between rheumatoid arthritis patients
and the general population. Arthritis Rheum 2007;56:3583-7.
22) Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis
patients with disease onset in the 1980s. Ann Rheum Dis
1999;58:11–4.
23) Kroot EJ, van Leeuwen MA, van Rijswijk MH, et al. No
increased mortality in patients with rheumatoid arthritis: up
to 10 years of follow up from disease onset. Ann Rheum Dis
2000;59:954–8.
24) Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L,
Ekbom A. Decreasing mortality in patients with rheumatoid
arthritis: results from a large population based cohort in
Sweden, 1964-95. J Rheumatol 2002;29:906–12.
25) Peltomaa R, Paimela L, Kautiainen H, Leirisalo-Repo M.
Mortality in patients with rheumatoid arthritis treated actively
from the time of diagnosis. Ann Rheum Dis 2002;61:889–94.
26) Carmona L, Descalzo MA, Perez-Pampin E, et al. All-cause
and cause-specific mortality in rheumatoid arthritis are not
greater than expected when treated with tumor necrosis
factor antagonists. Ann Rheum Dis 2007;66:880–5.
27) Sokka T, Mottonen T, Hannonen P. Mortality in early
“sawtooth” treated rheumatoid arthritis patients during the
first 8-14 years. Scand J Rheumatol 1999;28:282–7.
28) Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus
T, Wolfe F. The American College of Rheumatology 1991
revised criteria for the classification of global functional status
in rheumatoid arthritis. Arthritis Rheum 1992;35(5):498-502.
29) Reumatologia online - Artrite Reumatoide. Disponibile
online da: http://www.reumatologiaonline.com/main/medici/
artrite_reumatoide.php. [Ultimo accesso maggio 2010].
30) Klareskog L, Rönnelid J, Lundberg K, Padyukov L,
Alfredsson L. Immunity to citrullinated proteins in rheumatoid
arthritis. Annu Rev Immunol 2008;26:651-75.
31) American College of Rheumatology Subcommitte on
Rheumatoid Arthritis Guidelines. Guidelines for the
Management of Rheumatoid Arthritis. 2002 Update. Arthritis
Rheum 2002; 46:328-46.
32) Gabriel SE. The epidemiology of rheumatoid arthritis.
Rheum Dis Clin North Am 2001;27:269-81.
33) Alamanos Y, Voulgari PV, Drosos AA. Incidence and
Prevalence of Rheumatoid Arthritis, Based on the 1987
American College of Rheumatology Criteria: A Systematic
Review. Semin Arthritis Rheum 2006;36:182-8.
34) Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of
rheumatoid arthritis in the county of Troms, northern Norway.
J Rheumatol 2001;27:1386–9.
35) Gabriel SE, Crowson CS, O’Fallon WM. The epidemiology
of rheumatoid arthritis in Rochester, Minnesota, 1955–1985.
Arthritis Rheum 1999;42:415–20.
36) Simonsson M, Bergman S, Jacobsson LT, Petersson IF,
Svensson B. The prevalence of rheumatoid arthritis in Sweden.
Scand J Rheumatol 1999;28:340–3.
37) Symmons D, Turner G, Webb R, et al. The prevalence of
rheumatoid arthritis in the United Kingdom: new estimates for
a new century. Rheumatology 2002;41:793–800.
38) Power D, Codd M, Ivers L, Sant S, Barry M. Prevalence of
rheumatoid arthritis in Dublin, Ireland: a population based
survey. Ir J Med Sci 1999;168:197-200.
39) Aho K, Kaipiainen-Seppanen O, Heliovaara M, Klaukka
T. Epidemiology of rheumatoid arthritis in Finland. Semin
Arthritis Rheum 1998;27:325–34.
40) Drosos AA, Alamanos I, Voulgari PV, et al. Epidemiology
of adult rheumatoid arthritis in northwest Greece 1987–1995.
J Rheumatol 1997;24:2129-33.
41) Andrianakos A, Trontzas P, Christoyannis F, et al.
Prevalence of rheumatic diseases in Greece: a cross-sectional
population based epidemiological study. The ESORDIG Study.
J Rheumatol 2003;30:1589–601.
42) Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J,
Gabriel R, Laffon A. The prevalence of rheumatoid arthritis in
the general population of Spain. Rheumatology 2002;41:88-95.
43) Cimmino MA, Parisi M, Moggiana G, Mela GS, Accardo S.
Prevalence of rheumatoid arthritis in Italy: the Chiavari Study.
Ann Rheum Dis 1998;57:315-8.
44) Saraux A, Guedes C, Allain J, et al. Prevalence of
rheumatoid arthritis and spondyloarthropathy in Brittany,
France. Societe de Rheumatologie de l’Ouest. J Rheumatol
1999;26:2622–7.
45) Stojanovic R, Vlachinac H, Palic-Obradovic D, Janosevic
S, Adanja B. Prevalence of rheumatoid arthritis in Belgrade,
Yugoslavia. Br J Rheumatol 1998;37:729–32.
46) Spindler A, Bellomio V, Berman A, et al. Prevalence of
rheumatoid arthritis in Tucuman, Argentina. J Rheumatol
2002;29:1166-70.
47) Pountain G. The prevalence of rheumatoid arthritis in the
Sultanate of Oman. Br J Rheumatol 1991;30:24-8.
48) Akar S, Birlik M, Gurler O, et al. The prevalence of
rheumatoid arthritis in an urban population of Izmir-Turkey.
Clin Exp Rheumatol 2004;22:416-20.
49) Darmawan J, Muirden KD, Valkenburg HA, Wigley RD.
The epidemiology of rheumatoid arthritis in Indonesia. Br J
Rheumatol 1993;32:537-40.
50) Lau E, Symmons D, Bankhead C, MacGregor A, Donnan
S, Silman A. Low prevalence of rheumatoid arthritis in the
urbanized Chinese of Hong Kong. J Rheumatol 1993;20:1133-7.
C a p i t o l o 2 S 1 1